Company: CMND
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112329
Chunk: 48

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 48
---
, sale, lease, exchange or other disposition of all or substantially 
 all of the property of a corporation not in the usual and regular course of the corporation’s business, or a dissolution of the                
 corporation, are generally required to be approved by the holders of a majority of the outstanding stock entitled to vote on the matter,       
 unless the certificate of incorporation requires a higher percentage.                                                                          
 However, under the DGCL, mergers in which less                                                                                                 
 than 20% of a corporation’s stock outstanding immediately prior to the effective date of the merger is issued generally do not require         
 stockholder approval. In certain situations, the approval of a business combination may require approval by a certain number of the holders    
 of a class or series of shares. In addition, Section 251(h) of the DGCL provides that stockholders of a constituent corporation need not       
 vote to approve a merger if: (i) the merger agreement permits or requires the merger to be effected under Section 251(h) and provides          
 that the merger shall be effected as soon as practicable following the tender offer or exchange offer, (ii) a corporation consummates          
 a tender or exchange offer for any and all of the outstanding stock of such constituent corporation that would otherwise be entitled to        
 vote to approve the merger, (iii) following the consummation of the offer, the stock accepted for purchase or exchanges plus the stock         
 owned by the consummating corporation equals at least the percentage of stock that would be required to adopt the agreement of merger          
 under the DGCL, (iv) the corporation consummating the offer merges with or into such constituent corporation and (v) each outstanding          
 share of each class or series of stock of the constituent corporation that was the subject of and not irrevocably accepted for purchase        
 or exchange in the offer is to be converted in the merger into, or the right to receive, the same consideration to be paid for the shares      
 of such class or series of stock of the constituent corporation irrevocably purchased or exchanged in such offer.                              
 The DGCL does not contain a procedure comparable                                                                                               
 to a plan of arrangement under BCBCA.                                                                                                          |     | Under the BCBCA and our articles, certain extraordinary                                                                                     
 company alterations, such as changes to authorized share structure, continuances, into or out of province, certain amalgamations, sales,    
 leases or other dispositions of all or substantially all of the undertaking of a company (other than in the ordinary course of business)